Galera Therapeutics, Inc.

Quick facts

Marketed products

• Dextromethorphan HBr · Supportive Care; Respiratory
  Dextromethorphan HBr is a sigma-1 receptor agonist and NMDA receptor antagonist that reduces cough by suppressing the cough reflex center in the medulla.

Phase 2 pipeline

• Drug: GC4419

Phase 1 pipeline

• GC4419 IV
• GC4702 dry powder
• GC4702 lipid suspension
• GC4702 lipid suspension - Part 2
• GC4711 Oral Capsule G-101
• GC4711 Oral Capsule G-111
• GC4711 Oral Capsule G-112
• GC4711 Oral Capsule G-119
• GC4711 Oral Capsule G-125
• IV GC4419
• IV GC4711

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Galera Therapeutics, Inc. portfolio CI brief
• Galera Therapeutics, Inc. pipeline updates RSS